Navigation Links
Results From an Expanded Cohort Phase 1 Study Published in the New England Journal of Medicine Demonstrate a Majority of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Responded to Crizotinib (PF-02341066)
Date:10/27/2010

had received at least one prior therapy and five patients were treated in the first-line setting.(1)  This Part 2 expansion cohort study of patients with ALK-positive advanced NSCLC, independent of the number of previous chemotherapies, followed the completion of the dose-escalation study which enrolled 37 advanced cancer patients with various tumors, including NSCLC, colorectal, pancreatic and inflammatory myofibroblastic tumor (IMT) tumors.(8)

These data were previously presented at the 2010 American Society of Clinical Oncology Annual Meeting.(7)

About Crizotinib (PF-02341066)

Crizotinib (PF-02341066) is a first-in-class compound that inhibits the anaplastic lymphoma kinase, or ALK,(3) and is representative of Pfizer's personalized medicine approach to cancer treatment.  By inhibiting ALK, crizotinib (PF-02341066) blocks signaling in a number of cell pathways that may be critical for the growth and survival of tumor cells.(4)  Crizotinib (PF-02341066) is also an inhibitor of c-MET (mesenchymal endothelial transition factor).(3)

About Non-Small Cell Lung Cancer

Lung cancer is one of the most common cancers worldwide.(9)  NSCLC accounts for about 85 percent of lung cancer cases and remains difficult to treat, particularly in the metastatic setting. Approximately 75 percent of NSCLC patients are diagnosed late with metastatic, or advanced, disease, where the five-year survival rate is only 6 percent.(10,11)  In addition, the current standard of care for advanced NSCLC demonstrates a response rate of only about 15 percent.(12)  Approximately 3-5 percent of NSCLC tumors are ALK-positive.(4)

About Pfizer Oncology

Pfizer Oncology is committed to the discovery, investigation and development of innovative treatment options to improve the outlook for cancer patients worldwide.  Our strong pipeline, one of the most robust in the industry, is studied
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
5. Tapestry Reports Second Quarter 2007 Results
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... May 1, 2015  Misonix, Inc. (NASDAQ: ... designs, manufactures and markets innovative therapeutic ultrasonic products ... cosmetic surgery, laparoscopic surgery and other surgical applications, ... for the third quarter fiscal year 2015 on ... a conference call that same day, Thursday, May ...
(Date:5/1/2015)... May 1, 2015  Shares of Aerie Pharmaceuticals, Inc. ... value yesterday following the results of the Phase 3 ... Despite the trial failing to meet its end points, ... may come from future studies. An analyst ... current pipeline, financial review, analyst summary, valuation, and recommendation ...
(Date:4/30/2015)... April 30, 2015 Omnicell, Inc. (NASDAQ: OMCL ... solutions to healthcare systems, today announced results for its ... results: Revenue for the first quarter of 2015 was ... first quarter of 2014, and down $5.3 million or ... First quarter 2015 net income as reported in accordance ...
Breaking Medicine Technology:Misonix, Inc. To Report Third Quarter Fiscal Year 2015 Financial Results On Thursday, May 7, 2015 2All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2Omnicell Announces First Quarter 2015 Results 2Omnicell Announces First Quarter 2015 Results 3Omnicell Announces First Quarter 2015 Results 4Omnicell Announces First Quarter 2015 Results 5Omnicell Announces First Quarter 2015 Results 6Omnicell Announces First Quarter 2015 Results 7Omnicell Announces First Quarter 2015 Results 8Omnicell Announces First Quarter 2015 Results 9Omnicell Announces First Quarter 2015 Results 10Omnicell Announces First Quarter 2015 Results 11Omnicell Announces First Quarter 2015 Results 12Omnicell Announces First Quarter 2015 Results 13Omnicell Announces First Quarter 2015 Results 14Omnicell Announces First Quarter 2015 Results 15Omnicell Announces First Quarter 2015 Results 16Omnicell Announces First Quarter 2015 Results 17Omnicell Announces First Quarter 2015 Results 18Omnicell Announces First Quarter 2015 Results 19Omnicell Announces First Quarter 2015 Results 20Omnicell Announces First Quarter 2015 Results 21Omnicell Announces First Quarter 2015 Results 22Omnicell Announces First Quarter 2015 Results 23Omnicell Announces First Quarter 2015 Results 24Omnicell Announces First Quarter 2015 Results 25Omnicell Announces First Quarter 2015 Results 26Omnicell Announces First Quarter 2015 Results 27
(Date:5/2/2015)... Las Vegas, NV (PRWEB) May 02, 2015 ... vs. Pacquiao tickets for the long awaited event today, ... Las Vegas. Diehard boxing fans will be able to ... circuit events. , The fight that boxing fans have wanted ... a few months ago. Floyd “Money” Mayweather will step inside ...
(Date:5/2/2015)... 2015 ProText Kinetic 2 is a set ... Cut Pro X. ProText Kinetic 2 features 40 ... Cut Pro X . Easily create interactive text videos ... Studios' ProText Kinetic 2. , Using ProText Kinetic is as ... ProText Kinetic presets in the FCPX timeline. Playback the ...
(Date:5/2/2015)... 2015 “ Peachtree Audio ” was ... Report, which features the latest and coolest technology products ... special reporter for NewsWatch, conducted the review and shared ... , Music is an important part of people’s ... and given the royal treatment. Peachtree Audio does just ...
(Date:5/2/2015)... Southlake, TX (PRWEB) May 02, 2015 ... of skin laxity issues of the face, neck ... a new concept with real potential for the ... published by the ThermiHealth Clinical Advisory Council, ThermiGyn’s ... MD, FACOG, FACS, ACGE, concluded that ThermiGyn’s temperature ...
(Date:5/1/2015)... Texas (PRWEB) May 02, 2015 IDLife ... Texas, is proud to announce the addition of its ... Widerstrom is a life long athlete, growing up in ... passion after college by becoming a personal trainer and ... been the face of several TV shows highlighting her ...
Breaking Medicine News(10 mins):Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 3Health News:Pixel Film Studios Announced the Release of Protext Kinetic 2 for FPCX. 2Health News:Affordable High-End Audio Equipment was Featured on NewsWatch Television 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3Health News:IDLife LLC Announces New Partnership with Fitness Celebrity, Jen Widerstrom 2
... to help pharmaceutical companies find, evaluate and manage ... in the drug development lifecycleSAN FRANCISCO, April 21 ... drug development partnering site for the pharmaceutical development ... platform and website, goBalto.com. goBalto transforms the way ...
... Onboarding to improve HR processes; Intelius webinar announced for May 5 ... ... Intelius Screening Solutions LLC, a leading, on-demand employment checks ... agreement with onboarding pioneer KMS Software Company. This alliance will bring ...
... by encouraging others to do the same… and capture it on video. The ... world of difference in troubling times. , ... (Vocus) April 21, 2009 -- One of ... to commit a random act of kindness and lend a helping hand. Eye ...
... Ancient Minerals ultra pure topical magnesium chloride products to help spread ... ... San Ramon, CA (PRWEB) April 21, 2009 -- LL ... the growing list of international distributors for its Ancient Minerals ultra ...
... health databank promise to speed scientific discovery.MILWAUKEE, April ... announces the launch of its ... ORBIT . This dynamic research instrument may ... widely diverse library of specimens to be used ...
... Olmsted, MPH, CIC, of Ann Arbor, Michigan has been ... Achievement Award by the Association for Professionals in Infection ... to an infection preventionist who best exemplifies the ideals ... award will be presented at the APIC 36th Annual ...
Cached Medicine News:Health News:Contract Drug Development Resource, goBalto, Launches New Web-Based Platform, goBalto.com 2Health News:Contract Drug Development Resource, goBalto, Launches New Web-Based Platform, goBalto.com 3Health News:Intelius Screening Solutions Announces Agreement with KMS Software Company to Provide Pre-Integrated Employment Background Screening and Onboarding Solution 2Health News:Intelius Screening Solutions Announces Agreement with KMS Software Company to Provide Pre-Integrated Employment Background Screening and Onboarding Solution 3Health News:Intelius Screening Solutions Announces Agreement with KMS Software Company to Provide Pre-Integrated Employment Background Screening and Onboarding Solution 4Health News:Paying it Forward: Washington, DC LASIK Vision Care Practice Sponsors New Contest to Reward Good Deeds 2Health News:Paying it Forward: Washington, DC LASIK Vision Care Practice Sponsors New Contest to Reward Good Deeds 3Health News:Ancient Minerals Magnesium Oil Now Available in New Zealand 2Health News:Ancient Minerals Magnesium Oil Now Available in New Zealand 3Health News:Aurora Health Care Unveils ORBIT, A Cutting-Edge Research Instrument 2Health News:Aurora Health Care Unveils ORBIT, A Cutting-Edge Research Instrument 3Health News:Michigan Infection Preventionist Receives Carole Demille Award for Outstanding Service, Contribution to Profession 2Health News:Michigan Infection Preventionist Receives Carole Demille Award for Outstanding Service, Contribution to Profession 3
The XCHO method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of cholesterol in serum and plasma....
For the quantitative in vitro determination of alanine aminotransferase in serum or plasma....
... The Inion S-1™ Biodegradable Anteroir Cervical ... simultaneous conservative treatment with a collar), is ... cervical discectomy and fusion procedures as a ... block bone allografts or autografts., This device ...
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
Medicine Products: